[LS-08] Luncheon Seminar 08　Importance of oral antiparkinsonian agents dosing design for optimizing levodopa pharmacokinetics

[LS-08-1] Importance of oral antiparkinsonian agents dosing design for optimizing levodopa pharmacokinetics

Masahiro Nagai (Department of Neurology and Clinical Pharmacology, Ehime University Hospital, Japan)